
Buy HEP-1 (Gepon) Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

Buy HEP-1 (Gepon) Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA on Request
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA on Request
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
What is HEP-1 (Gepon)?
HEP-1 (also called Gepon) is a synthetic 10-amino-acid immune-modulating peptide developed in Russia. It acts on toll-like receptors and is studied in laboratory research for its effects on antiviral and anti-inflammatory immune signaling.
- A short synthetic peptide studied for its effects on immune-system signaling
- Studied in laboratory research for antiviral and immune signaling activity
- Investigated for anti-inflammatory effects and activity in wound-repair studies
- Works on the innate immune system through toll-like receptor signaling
For research use only. Not approved for human therapeutic use.
HEP-1, a synthetic hepcidin-derived peptide based on the Liver-Expressed Antimicrobial Peptide 1 (LEAP-1) family, is a cysteine-rich antimicrobial peptide fragment with a molecular weight of 2789.4 g/mol. Hepcidin peptides are characterised by a high cysteine content forming multiple intramolecular disulfide bridges that create a compact, hairpin-like beta-sheet structure. The full-length mature hepcidin (hepcidin-25) consists of 25 amino acids with four disulfide bonds and eight cysteine residues, and truncated bioactive fragments including hepcidin-20 have also been characterised in the published literature. Produced via solid-phase peptide synthesis, HEP-1 is associated with ferroportin-mediated iron homeostasis and innate antimicrobial signalling pathways in preclinical research.
Hepcidin peptides occupy a central position in preclinical iron metabolism and innate immunity research. The full-length peptide was first isolated from human blood ultrafiltrate and has been characterised as the principal hormonal regulator of systemic iron homeostasis, acting through direct binding and internalisation of ferroportin, the sole known cellular iron exporter. In vitro studies have documented that hepcidin binds ferroportin and induces its internalisation and degradation, reducing cellular iron export, establishing this binding-and-internalisation mechanism as the molecular basis for hepcidin’s control of cellular iron efflux [1]. In vivo rodent studies have investigated the relationship between hepcidin peptide administration and systemic iron distribution, documenting that synthetic hepcidin produces rapid, dose-dependent hypoferremia in mice and concentrates in ferroportin-containing organs, characterising the peptide as a direct regulator of systemic iron availability in vivo [2], making HEP-1 a reference compound in iron-metabolism and innate-immunity research examining hepcidin–ferroportin regulation of cellular and systemic iron handling in preclinical models.
HEP-1 is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 14 June 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Related Compounds

N-Acetyl Epitalon
Mol. Wt.
432.38 g/mol
Purity
≥98%
CAS No.
N/A (modified Epitalon form)

Cartalax
Mol. Wt.
333.31 g/mol
Purity
≥98%
CAS No.
N/A (Khavinson bioregulator)

Prostamax
Mol. Wt.
487.51 g/mol
Purity
≥98%
CAS No.
N/A (Khavinson bioregulator)
Select Size
Get notified when this batch is released
Enter your email and we'll let you know as soon as this product is available again.
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis and MSDS available on request.



